Belluscura plc (AIM: BELL)

Market Cap	16.84M
Revenue (ttm)	1.43M
Net Income (ttm)	-14.72M
Shares Out	168.41M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,857
Open	9.50
Previous Close	10.00
Day's Range	9.50 - 9.50
52-Week Range	7.00 - 27.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 27, 2024

About Belluscura

Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2015
• Employees: 35
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: BELL

Financial Performance

In 2023, Belluscura's revenue was $825,409, a decrease of -40.96% compared to the previous year's $1.40 million. Losses were -$18.52 million, 127.1% more than in 2022.

Financial numbers in USD